Showing results (71-80 of 95) with videos related to
Sort By:
Pageof 10
Journal of Medicinal Chemistry|June 12, 2008
Synthesis and pharmacological characterization of chiral pyrrolidinylfuran derivatives: the discovery of new functionally selective muscarinic agonistsSerena Scapecchi, Marta Nesi, Rosanna Matucci, et al.Journal of Enzyme Inhibition and Medicinal Chemistry|April 8, 2020
6,7-Dimethoxy-2-phenethyl-1,2,3,4-tetrahydroisoquinoline amides and corresponding ester isosteres as multidrug resistance reversersLaura Braconi, Gianluca Bartolucci, Marialessandra Contino, et al.Bioorganic & Medicinal Chemistry|December 19, 2012
New structure-activity relationship studies in a series of N,N-bis(cyclohexanol)amine aryl esters as potent reversers of P-glycoprotein-mediated multidrug resistance (MDR)Francesca Orlandi, Marcella Coronnello, Cristina Bellucci, et al.European Journal of Pharmacology|January 22, 2024
The novel non-hallucinogenic compound DM506 (3-methyl-1,2,3,4,5,6-hexahydroazepino[4,5-b]indole) induces sedative- and anxiolytic-like activity in mice by a mechanism involving 5-HT<sub>2A</sub> receptor activationHugo R Arias, Deborah Rudin, Dustin J Hines, et al.Journal of Medicinal Chemistry|March 17, 2006
Highly chiral muscarinic ligands: the discovery of (2S,2'R,3'S,5'R)-1-methyl-2-(2-methyl-1,3-oxathiolan-5-yl)pyrrolidine 3-sulfoxide methyl iodide, a potent, functionally selective, M2 partial agonistSerena Scapecchi, Rosanna Matucci, Cristina Bellucci, et al.Molecules (Basel, Switzerland)|July 27, 2024
Dual Inhibitors of P-gp and Carbonic Anhydrase XII (hCA XII) against Tumor Multidrug Resistance with Piperazine ScaffoldLaura Braconi, Chiara Riganti, Astrid Parenti, et al.Journal of Medicinal Chemistry|September 14, 2007
Design, synthesis, and preliminary pharmacological evaluation of new quinoline derivatives as nicotinic ligandsLuca Guandalini, Monica Norcini, Katia Varani, et al.ACS Chemical Neuroscience|October 19, 2020
(<i>E</i>)-3-Furan-2-yl-<i>N</i>-<i>p</i>-tolyl-acrylamide and its Derivative DM489 Decrease Neuropathic Pain in Mice Predominantly by α7 Nicotinic Acetylcholine Receptor PotentiationHugo R Arias, Carla Ghelardini, Elena Lucarini, et al.Neurochemistry International|June 5, 2024
Novel psychoplastogen DM506 reduces cue-induced heroin-seeking and inhibits tonic GABA currents in the Prelimbic CortexKassandra Looschen, Shailesh Narayan Khatri, Malabika Maulik, et al.Journal of Medicinal Chemistry|January 15, 2009
N,N-bis(cyclohexanol)amine aryl esters: a new class of highly potent transporter-dependent multidrug resistance inhibitorsCecilia Martelli, Daniela Alderighi, Marcella Coronnello, et al.Pageof 10